Afuco™ Anti-IGF1 and IGF2 ADCC Therapeutic Antibody (Xentuzumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to IGF1 and IGF2. xentuzumab is a humanized monoclonal antibody that can be potentially used in the treatment of Solid tumors. It neutralises IGF-1 and IGF-2 function.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-475CQ |
| Pricing | Inquiry |
| Host | Human |
| Target | IGF1 and IGF2 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | ELISA, IHC, FC, IP, IF, Neut |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |